Can a new drug shrink Hard-to-Treat tumors?
Disease control
Not yet recruiting
This study tests an experimental drug called ATX-898 in people with advanced solid tumors that have spread or cannot be removed by surgery. The trial has two parts: first, ATX-898 is given alone to find the safest dose; second, it is combined with other anti-cancer drugs to see i…
Phase: PHASE1, PHASE2 • Sponsor: Antares Therapeutics, Inc • Aim: Disease control
Last updated Aug 18, 2026 01:00 UTC